Literature DB >> 12030796

Induction of nephrotoxic serum nephritis in inbred mice and suppressive effect of colchicine on the development of this nephritis.

Shih-Ming Chen1, Takuya Mukoyama, Noriko Sato, Shin-Ichi Yamagata, Yuichiro Arai, Nobunori Satoh, Shiro Ueda.   

Abstract

Accelerated nephrotoxic serum (NTS) nephritis is successfully produced in C57BL/6 mice, using anti-murine glomerular basement membrane (GBM) rabbit antiserum. Anti-murine GBM rabbits antiserum was obtained by immunization of New Zealand white rabbit with trypsinized GBM antigen from normal C57BL/6 mice. Preimmunization with normal rabbit IgG and injection with 150 microl of NTS induced typical NTS nephritis with cellular proliferation in glomeruli, occlusion of glomerular loops, crescents, tubulointerstitial changes and hyperazotemia within 14 days. Polymorphonuclear leucocytes (PMN) have an important role in induction and development of NTS nephritis. Furthermore, clinically used colchicine is thought to suppress functions of PMN. Therefore, the therapeutic effect of colchicine on NTS nephritis was examined. The histological score (HS) of the group treated with 60 microg kg (-1) of colchicine (2.8 +/- 0.5) was significantly lower than that of positive control group (4.03 +/- 0.3).The direct immunofluorescent microscopic study revealed that there is no quantitative difference in the deposition of rabbit IgG, mouse IgG and C3 in GBM between these two groups. Urinary protein excretion and hyperazotemia were significantly suppressed by treatment with 60 microg kg (-1) of colchicine. A NTS nephritis model was established, it was found that colchicine may have a suppressive effect on the development of glomerular nephritis. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030796     DOI: 10.1006/phrs.2002.0948

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

1.  Prevention of Renal Scarring in Acute Pyelonephritis by Probiotic Therapy: an Experimental Study.

Authors:  Nastaran Sabetkish; Shabnam Sabetkish; Mohammad Javad Mohseni; Abdol-Mohammad Kajbafzadeh
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

2.  Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury.

Authors:  Juan Carlos Q Velez; Ehtesham Arif; Jessalyn Rodgers; Megan P Hicks; John M Arthur; Deepak Nihalani; Evelyn T Bruner; Milos N Budisavljevic; Carl Atkinson; Wayne R Fitzgibbon; Michael G Janech
Journal:  J Am Soc Nephrol       Date:  2017-02-15       Impact factor: 10.121

Review 3.  Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review.

Authors:  Robert Klopfleisch
Journal:  BMC Vet Res       Date:  2013-06-21       Impact factor: 2.741

4.  Toxicological Evaluation of Novel Cyclohexenone Derivative in an Animal Model through Histopathological and Biochemical Techniques.

Authors:  Muhammad Kamil; Arifa Fatima; Sami Ullah; Gowhar Ali; Rasool Khan; Naila Ismail; Mughal Qayum; Marius Irimie; Catalina Georgeta Dinu; Hanadi Talal Ahmedah; Maria Elena Cocuz
Journal:  Toxics       Date:  2021-05-25

5.  Rapidly progressive glomerulonephritis in a patient with renal amyloidosis: Case report and review of the literature.

Authors:  Y J Anupama; M Vankalakunti
Journal:  Indian J Nephrol       Date:  2012-09

6.  Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis.

Authors:  Makoto Araki; Takeshi Matsubara; Hideharu Abe; Kazuo Torikoshi; Akira Mima; Noriyuki Iehara; Atsushi Fukatsu; Toru Kita; Hidenori Arai; Toshio Doi
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

7.  Utilizing methylglyoxal and D-lactate in urine to evaluate saikosaponin C treatment in mice with accelerated nephrotoxic serum nephritis.

Authors:  Chia-Yu Lin; Jen-Ai Lee; Po-Yeh Lin; Shih-Chun Hua; Pei-Yun Tsai; Bi-Li Chen; Chia-En Lin; Tzong-Huei Lee; Shih-Ming Chen
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.